NDC 16729-250

bendamustine hydrochloride

Bendamustine Hydrochloride

bendamustine hydrochloride is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Accord Healthcare, Inc.. The primary component is Bendamustine Hydrochloride.

Product ID16729-250_ef547fb0-34bb-6354-e053-2a95a90a90cb
NDC16729-250
Product TypeHuman Prescription Drug
Proprietary Namebendamustine hydrochloride
Generic NameBendamustine Hydrochloride
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-12-07
Marketing CategoryANDA /
Application NumberANDA205574
Labeler NameAccord Healthcare, Inc.
Substance NameBENDAMUSTINE HYDROCHLORIDE
Active Ingredient Strength25 mg/5mL
Pharm ClassesAlkylating Activity [MoA], Alkylating Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 16729-250-03

1 VIAL, SINGLE-DOSE in 1 CARTON (16729-250-03) > 5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-12-07
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "bendamustine hydrochloride" or generic name "Bendamustine Hydrochloride"

NDCBrand NameGeneric Name
10019-079BENDAMUSTINE HYDROCHLORIDEbendamustine hydrochloride
16729-250bendamustine hydrochloridebendamustine hydrochloride
16729-251bendamustine hydrochloridebendamustine hydrochloride
42367-520BENDAMUSTINE HYDROCHLORIDEbendamustine hydrochloride
42367-521BELRAPZObendamustine hydrochloride
63459-348Bendekabendamustine hydrochloride
63459-390TREANDABendamustine Hydrochloride
63459-391TREANDABendamustine Hydrochloride
71225-120VIVIMUSTABENDAMUSTINE HYDROCHLORIDE
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.